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Tibialis Posterior Tenosynovitis and Associated
Pes Plano Valgus in Rheumatoid Arthritis:
Electromyography, Multisegment Foot Kinematics,
and Ultrasound Features
RUTH BARN,1 DEBORAH E. TURNER,1 DANIEL RAFFERTY,1 ROGER D. STURROCK,2 AND
JAMES WOODBURN1
Objective. To compare electromyographic (EMG), kinematic, kinetic, and ultrasound (US) features of pes plano valgus
associated with US-conﬁrmed tibialis posterior (TP) tenosynovitis in rheumatoid arthritis (RA) and healthy control
subjects.
Methods. In this cross-sectional study, patients with RA and US-conﬁrmed tenosynovitis of TP underwent gait analysis,
including 3-dimensional kinematics, kinetics, and intramuscular EMG of TP, and ﬁndings were compared with a group
of healthy individuals. The RA group also underwent B mode and power Doppler US scanning of the TP tendon to assess
and score levels of pathology.
Results. Ten patients with RA, median (range) disease duration of 3 years (1–18 years), and 5 control subjects were
recruited. Compared to control subjects, the RA patients walked slower and presented with moderate levels of foot-
related disability. The mean  SD Disease Activity Score in 28 joints was 4.6  1.6. Increased magnitude of TP activity
was recorded in the RA group compared to controls in the contact period of stance (P  0.007), in conjunction with
reduced ankle joint power (P  0.005), reduced navicular height in the medial arch (P  0.023), and increased forefoot
dorsiﬂexion (P 0.027). TP tendon thickening, ﬂuid, and power Doppler signal were observed in the majority of patients.
Conclusion. This study has demonstrated, for the ﬁrst time, increased TP EMG activity in the presence of US-conﬁrmed
TP tenosynovitis in RA. Altered muscle function occurred in conjunction with suboptimal mechanics, moderate levels of
tendon pathology, and active disease. Targeted therapy may be warranted to reduce inﬂammation and mechanically
off-load diseased tendon states.
INTRODUCTION
Rheumatoid arthritis (RA) is an inﬂammatory polyarthritis
that frequently affects the joints and soft tissues of the feet
(1). Tibialis posterior (TP) tenosynovitis has a reported
prevalence between 13–64% in RA, dependent upon the
diagnostic criteria employed (2). The condition is associ-
ated with a progressive ﬂat foot deformity (pes plano val-
gus [PPV]) and signiﬁcant walking-related disability (2).
Both mechanical and inﬂammatory factors have been pos-
tulated in the development of this complex clinical prob-
lem (3), but deﬁnitive data are lacking. Furthermore, the
functional contribution of the TP muscle when PPV and
TP tenosynovitis coexist is not known.
TP activity in RA has previously been investigated using
intramuscular electromyography (EMG) (4). The results
demonstrated increased TP activity in an RA group with
PPV compared to those without (4). However, the study
was conducted in patients with longstanding disease du-
ration and the pathologic state of the tendon was un-
known. Similar results have been reported in ﬂat foot (5)
and TP tendon dysfunction patients without RA (6), with
both studies concluding that the increased activity oc-
curred in an attempt to prevent collapse of the medial
longitudinal arch (MLA). In addition to alterations to mus-
cle activity, PPV in RA is associated with structural and
functional deterioration of the rear- and midfoot joints
(7–9). In an RA population, TP tendon disease and PPV
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frequently coexist, yet the relationship between the two
remains ambiguous. Some authors speculate that soft tis-
sue changes to the TP tendon and laxity of supporting
structures cause the valgus rearfoot alignment (10–12).
Others suggest that subtalar and midfoot arthritis and sy-
novitis in the context of weight-bearing stresses are more
likely to be the cause (11,13–16). Recent advances in im-
aging and multisegment foot models represent an oppor-
tunity to better understand the condition by combining
biomechanical features with imaging of tendon pathology
in RA.
High-resolution ultrasound (US) has been reported as
the gold standard for the investigation of tendons (17–19).
US facilitates detailed examination of tendon features, in-
cluding assessment of internal structure of tendon body,
tendon sheath, and the presence of hyperemia suggestive
of active inﬂammation via color or power Doppler signal
(PDS) (20,21). The aim of this study is to provide a com-
prehensive description of the biomechanical and inﬂam-
matory features of TP tenosynovitis in RA by combining
EMG with 3-dimensional (3-D) motion analysis and high-
resolution US. These features were compared to healthy
individuals for analysis.
PATIENTS AND METHODS
Patients. Patients were recruited from outpatient clinics
at Glasgow Royal Inﬁrmary and Gartnavel General Hospi-
tal, Glasgow, UK. Patients were eligible for inclusion if
they had a conﬁrmed diagnosis of RA based on the 1987
American College of Rheumatology criteria (22), passively
correctable PPV deformity, and US-conﬁrmed tenosyno-
vitis at a screening appointment. PPV is a complex multi-
planar deformity with the following features: valgus rear-
foot alignment, MLA collapse, and medial bulging of the
talonavicular joint (4,23), in conjunction with abduction of
the forefoot (8). Patients exhibiting these features in re-
laxed standing were included in the study. Tenosynovitis
was deﬁned as “hypoechoic or anechoic thickened tissue
with or without ﬂuid within the tendon sheath which may
or may not exhibit Doppler signal” (24). Presence was
conﬁrmed by diagnostic US prior to entry to the study.
Control subjects were recruited from Glasgow Caledonian
University staff. Subjects were included if they had no
history of previous or current musculoskeletal or neuro-
logic disease affecting the lower leg and absence of foot
pain and deformity. The study was conducted in accor-
dance with the Declaration of Helsinki, and ethical ap-
proval was obtained from the West of Scotland Local Re-
search Ethics Committee and NHS Greater Glasgow and
Clyde Research and Development.
Demographic, disease, and clinical assessment. The
participants’ age, sex, and disease duration were recorded.
A core set of clinical variables were recorded: tender and
swollen foot joint count undertaken by a single clinician
(RB); foot posture using the Structural Index (16); foot-
related impairment and disability using the Foot Impact
Scale for RA (25); and global disability using the Health
Assessment Questionnaire (26). Disease activity was re-
corded using a composite measure, the Disease Activity
Score in 28 joints (DAS28) (27), including erythrocyte
sedimentation rate within 2 weeks of assessment. Visual
analog scales (100 mm) were used to record foot pain,
general health, and arthritis pain. The most symptomatic
leg was studied in the RA group; in the control group the
studied leg was randomly selected by the participant se-
lecting a number between 1 and 10, then was randomly
assigned to the right or left leg.
Biomechanical analysis. A 12-camera 120 Hz, 3-D mo-
tion analysis system (Qualisys Oqus) was used to track
the motion during the gait of a multisegmented foot model
comprising functional units for the shank, rearfoot, mid-
foot, and forefoot (28). A single force plate (Kistler) re-
corded ground reaction forces simultaneously. Visual 3-D
software (C-Motion) was used to extract a core set of func-
tional variables: peak ankle joint moments and power,
peak rearfoot eversion, midfoot inversion, forefoot abduc-
tion, forefoot dorsiﬂexion, and lowest navicular height.
Walking speed was self-selected and recorded using tim-
ing gates (Brower Timing Systems). Trials exceeding 5%
of the self-selected speed were excluded, and a total of 5
walking trials were included for each participant.
EMG analysis. Four channels of surface EMG data were
recorded for tibialis anterior, soleus, peroneus longus, and
medial gastrocnemius using Trigno (Delsys) wireless sur-
face electrodes applied following the Surface Electro-
MyoGraphy for the Non-Invasive Assessment of Muscles
guidelines (29). Surface electrodes had a single differential
conﬁguration, interelectrode distance of 10 mm, 4-bar for-
mation, bandwidth of 20–450 Hz, and 99.9% silver con-
tact material. Intramuscular EMG of TP was undertaken
using bi-polar stainless-steel nylon-coated ﬁne wire elec-
trodes (Motion Lab Sytems). Electrodes were inserted un-
der US guidance (Esaote Mylab 70) using a 13–4-MHz
linear array transducer via the posterior-medial approach
at 50% of the distance between the medial malleolus and
the tibial tubercle (30). Placement of the electrode was
veriﬁed by checking the signal while applying manual
Signiﬁcance & Innovations
● Innovative use of ultrasound (US) technology per-
mits ﬁne-wire electromyographic (EMG) studies of
tibialis posterior function during gait.
● This study provides a novel, detailed description
of mechanical and inﬂammatory factors in US-
conﬁrmed tibialis posterior tenosynovitis in rheu-
matoid arthritis (RA).
● This is the ﬁrst study to demonstrate abnormal
tibialis posterior EMG activity in a cohort of pa-
tients with RA and US-conﬁrmed tibialis posterior
tenosynovitis; this was observed in the presence of
suboptimal biomechanics and moderate levels of
tendon disease.
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resistance in the direction of dorsiﬂexion and eversion
while participants plantarﬂexed and inverted; the signal
was also checked when participants ﬂexed their toes to
ensure the electrode was not placed in the ﬂexor digitorum
longus muscle. Discrete variables were recorded for each
muscle relating to the peak of activity and the time of peak
activity during contact and combined midstance/propul-
sive (MS/P) phases of stance, based on when the muscles
were most active (31).
US assessment of tenosynovitis. High-resolution US
was undertaken by a single experienced sonographer
(DET) using an Esaote MyLab 70 with 15–7-MHz linear
array transducers. TP was viewed and images recorded
along the length of the tendon at 3 locations: medial mal-
leolus, navicular insertion, and midway between the 2
points. Measurements of tendon diameter and ﬂuid were
recorded in the retro malleolar region and compared with
published literature (32,33). PDS was recorded using a
pulse repetition frequency of 750 Hz and the Doppler
gain was optimized to regional site (34). The levels of PDS
were graded using a 4-point semiquantitative scale (absent/
minor/moderate/major) (35). Only the RA group under-
went US scanning of TP; normative values for tendon
diameter and ﬂuid based on the work of Schmidt et al (33)
and Premkumar et al (32) were used for comparison.
Data processing. All EMG signals were high-pass ﬁl-
tered with a cutoff frequency of 20 Hz. All EMG data
were subject to a root mean squared moving average of
25 msec. EMG data were normalized to maximum volun-
tary isometric contractions (MVICs); 3 MVICs were re-
corded for each muscle following completion of walking
trials. The MVIC data were recorded for 5 seconds with a
gradual buildup of 2 seconds prior to maximal effort for
the ﬁnal 3 seconds. The peak value from a 500 msec
window obtained from the 3-second maximal effort of the
MVIC was used as the reference value, similar to the meth-
ods reported elsewhere (36). All participants were verbally
encouraged in a standard manner during the MVICs, and
a 1-minute recovery period was set between repetitions.
Kinematic data were subject to a fourth-order Butterworth
low-pass ﬁlter with a cutoff of 6 Hz.
Statistical analysis. Statistical analyses were performed
using SPSS, version 17.0. Demographic and group charac-
teristics were summarized with the mean and SD or me-
dian and range. Biomechanical and EMG data were nor-
malized to 100% of stance and compared using the
Student’s t-test or Mann-Whitney U test, according to the
distribution characteristics of the data.
RESULTS
Group characteristics. Ten patients (6 women, 4 men),
with a mean SD age of 50 9 years and a median (range)
disease duration of 3 years (1–18 years), were recruited
(Table 1). Five control subjects, with a mean  SD age of
47  6 years, were also recruited. Patients with RA and TP
tenosynovitis walked on average 20% slower than the
control group and had moderate levels of foot-related im-
pairment and disability. Demographics of the groups were
comparable with the exception of body mass index (BMI);
in the RA group, 2 participants were within the ideal
range, 3 were overweight, and 5 were obese. In the control
group, 3 participants were within the ideal range and 2
were overweight. All patients with RA were managed on
disease-modifying antirheumatic drug therapy and 2 pa-
tients were receiving biologic drug therapy. Moderately
Table 1. Demographic and disease characteristics*
Variable
RA group
(n  10)
Control group
(n  5)
Age, years 50  9 47  6
Sex, M:F 4:6 2:3
Disease duration, median (range) years 3 (1–18) –
Body mass index, kg/m2 30  6 24  1
DAS28 score 4.6  1.6 –
FIS impairment subscale (range 0–21) 14  3 0  1
FIS disability subscale (range 0–30) 21  5 0  0
HAQ score 1.3  0.6 0  0
Foot pain VAS (0–100 mm) 46  19 1  1
General health VAS (0–100 mm) 44  26 1  2
Arthritis VAS (0–100 mm) 51  19 –
Structural index: rearfoot (range 0–7) 2  1 1  1
Structural index: forefoot (range 0–12) 4  3 3  3
Swollen foot joint count (range 0–14) 0  1 0  0
Tender foot joint count (range 0–14) 7  3 0  0
Barefoot walking speed (meters/second) 1.00  0.14 1.25  0.15
Weight-bearing rearfoot alignment, degrees† 7  3 4  2
* Values are the mean  SD unless indicated otherwise. RA  rheumatoid arthritis; DAS28  Disease
Activity Score in 28 joints; FIS  Foot Impact Scale for RA; HAQ  Health Assessment Questionnaire;
VAS  visual analog scale.
† By convention, eversion angles are expressed as negative.
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active disease states were present in the RA cohort with a
mean  SD DAS28 score of 4.6  1.6.
Biomechanical features. In comparison to healthy con-
trol subjects, the RA group demonstrated a trend towards
abnormal intersegment foot motion and force in the pres-
ence of slower walking speed. The RA group demonstrated
a trend towards characteristic features of PPV: reduced
medial longitudinal arch height (planus), increased rear-
foot eversion (valgus), and forefoot abduction (Table 2 and
Figure 1). However, when key discrete variables were
compared between the groups, only 3 of 8 variables had a
Table 2. Key kinematic and kinetic variables*
Segment and variable
RA
barefoot
(n  10)
Control
barefoot
(n  5)
Mean
difference
(95% CI) P†
Rearfoot
Peak eversion, degrees 5  5 3  5 2 (8, 4) 0.53
Peak plantarﬂexion, degrees 6  3 7  4 2 (3, 6) 0.44
Peak ankle joint power, W/kg 1.7  0.8 3.1  0.6 1 (2, 0) 0.005‡
Peak ankle joint moment, Nm/kg 1.2  0.3 1.4  0.1 0.2 (0, 0.5) 0.11
Midfoot
Lowest navicular height, mm 29  9 41  7 12 (22, 2) 0.02‡
Peak inversion, degrees 7  6 2  5 6 (1, 13) 0.08
Forefoot
Peak abduction, degrees 5  7 2  4 6 (13, 1) 0.07
Peak dorsiﬂexion, degrees 8  2 6  1 3 (0, 5) 0.02‡
* Values are the mean  SD unless otherwise indicated. RA  rheumatoid arthritis; 95% CI  95%
conﬁdence interval.
† By independent-samples t-test.
‡ Signiﬁcant at P  0.05.
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Figure 1. Motion and force time curves. Shaded area shows the mean  SD for 5 control participants; bars show the mean  SD for 10
rheumatoid arthritis patients.
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P value less than 0.05 and the 95% conﬁdence interval of
the mean difference for the remaining variables crossed
zero. The 3 variables were reduced ankle joint power,
lower navicular height, and increased peak forefoot dorsi-
ﬂexion compared to controls.
EMG features. There was a trend for increased EMG
activity of the TP and tibialis anterior muscles and re-
duced soleus activity in the RA group compared to con-
trols. EMG data were not normally distributed (9 variables
negatively skewed, 5 variables positively skewed) and are
summarized accordingly in Table 3 and Figure 2. There
was also evidence of altered TP timing, which is sugges-
tive of earlier peak of activity in the contact phase and later
peak of activity in the MS/P phase, and a trend towards
earlier peak of soleus activity but with reduced magnitude.
Magnitude of TP in the contact phase, timing of TP during
contact and MS/P, and timing of soleus during MS/P had
signiﬁcance values of P  0.05. However, when adjusted
for multiple testing these were no longer signiﬁcant.
US features. Measurement of TP tendon diameter was
recorded in the transverse and longitudinal views at the
medial malleolus level, and the longitudinal:transverse
ratio was calculated. Additionally, ﬂuid was measured in
both views; all data were normally distributed and values
are summarized in Table 4 as mean  SDs. The range of
values is also included to further describe the cohort.
Compared to normal values from the literature, the TP
tendon was thickened in the longitudinal view, and levels
of ﬂuid were elevated in the patients with RA and TP
tenosynovitis. Levels of PDS were also recorded at 3 sites;
all participants had conﬁrmed PDS in 1 or more sites. The
greatest level of pathology was recorded at the navicular
insertion region, where 5 of 10 scored as moderate, 1 of 10
as major, 1 of 10 as minor, and 3 of 10 as absent.
Table 3. Key discrete EMG variables*
Muscle and variable
RA
barefoot
(n  10)
Control
barefoot
(n  5) P†
Medial gastrocnemius
Peak MS/P 83 (59–128) 81 (65–106) 1.00
Time of peak MS/P 46 (34–65) 63 (52–69) 0.19
Peroneus longus
Peak contact 43 (28–86) 19 (6–65) 0.12
Time of peak contact 9 (5–15) 5 (4–12) 0.35
Peak MS/P 70 (43–105) 39 (36–59) 0.11
Time of peak MS/P 68 (38–77) 69 (56–78) 0.75
Soleus
Peak MS/P 69 (31–84) 95 (68–123) 0.08
Time of peak MS/P 61 (48–63) 64 (63–67) 0.04‡
Tibialis anterior
Peak contact 49 (32–56) 27 (16–44) 0.07
Time of peak contact 6 (0–6) 0 (0–8) 0.94
Tibialis posterior
Peak contact 48 (35–116) 22 (14–28) 0.007‡
Time of peak contact 13 (8–15) 7 (5–8) 0.03‡
Peak MS/P 94 (56–261) 51 (22–80) 0.06
Time of peak MS/P 64 (60–68) 74 (72–75) 0.01‡
* Values are the median (interquartile range) unless indicated oth-
erwise. Magnitude data expressed as percentage of maximum vol-
untary isometric contractions; temporal data expressed as percent-
age stance. EMG  electromyography; RA  rheumatoid arthritis;
MS/P  combined midstance/propulsive phase gait.
† By Mann-Whitney U test.
‡ Signiﬁcant at P  0.05.
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Figure 2. Electromyography activation proﬁles. Data expressed relative to maximum voluntary isometric contractions (MVICs) during the
stance phase. Shaded area shows the mean  SD for 5 control participants; bars show the mean  SD for 10 rheumatoid arthritis patients.
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DISCUSSION
The aim of this study was to provide a comprehensive
description of TP tenosynovitis associated with PPV in
RA, including imaging of tendon pathology, and to com-
pare these features to normal values. The current study is
the ﬁrst to investigate EMG activity of TP in RA-associated
PPV with TP tenosynovitis conﬁrmed by US imaging. The
increased TP activity occurred in conjunction with abnor-
mal mechanical function, moderate levels of TP tendon
pathology on US, and reduced walking speed. Abnormal
gait patterns and reduced walking speed have been previ-
ously reported in RA (7,8,16). The results of this study
build upon previous ﬁndings to attempt to understand the
relationship between muscle activity and joint motion and
forces. The results must be considered within the context
of moderate levels of foot-related impairment and disabil-
ity and active disease states.
TP acts as the primary dynamic stabilizer of the rearfoot
and the MLA (37,38). Increased TP activity has been pos-
tulated as a potential mechanism to prevent collapse of
the MLA in RA and non-RA ﬂatfoot cohorts (4,5) and a
TP tendon dysfunction cohort (6). In the present study,
the increased magnitude of activity was pronounced in
the contact period of stance when the foot adapts to the
weight-bearing surface. However, the increased activity
was not sufﬁcient to prevent midfoot collapse as demon-
strated by lower navicular height. There was also evidence
of altered timing of TP, which is suggestive of earlier peak
of activity in the contact phase and later peak of activity in
the MS/P phase, as well as a trend toward earlier peak
soleus activity but with reduced magnitude. There was
also a trend toward increased tibialis anterior activity in
agreement with ﬁndings in ﬂatfoot and TP tendon dys-
function cohorts (5,6), although this did not reach statisti-
cal signiﬁcance. The trend for increased tibialis anterior
activity may be an attempt to assist the TP muscle to
control initial rapid pronation during contact. No other
abnormal muscle activation patterns were evident in this
cohort. Previous studies have reported high levels of vari-
ation in EMG proﬁles in healthy adults (31), which may be
confounded by compensatory mechanisms in RA. Inter-
subject variability highlights the person-speciﬁc muscle
activation proﬁles, which in RA can be further confounded
by adaptive strategies to localized joint/soft tissue pain
that was reported in the cohort. Moreover, loss of muscle
mass and strength associated with RA (39) may further
contribute to variation.
In RA, the joints of the rear- and midfoot are vulnerable
to inﬂammatory damage, leading to altered joint congru-
ence, ligament and capsule damage, and instability (40).
This manifests clinically as localized pain, tenderness,
and deformity, and functionally as gait adaptations to off-
load painful structures (41). Differences were detected in
the midfoot and forefoot in this cohort compared to control
subjects, in line with previous research (42), yet only mild
to moderate rearfoot valgus was recorded compared to
heterogeneous (3), severely deformed (8), and early RA
cohorts (43). PPV is a multiplanar deformity affecting mul-
tiple segments within the foot to varying degrees. How-
ever, repeated forces applied during gait may lead to pro-
gressive deformity if left untreated (7). In the present
study, reduced ankle joint power was evident in the RA
group, and this can be attributed to reduced walking
speed. Altered joint motion and forces may increase stress
on the TP tendon, and the BMI status of the RA group may
compound this factor. Furthermore, abnormal kinematics
found in ﬂatfoot has been reported to increase the length of
the TP muscle (44). In conjunction with joint instability
and pain in RA, these features may potentially combine to
result in the complex adaptations as observed.
Stress on a tendon is related to muscle activity and
tendon size (45). Therefore, increased TP activity may
potentially contribute to the development of tendon dis-
ease in this population. The navicular insertion of TP has
been described as an “enthesis organ” and is a known site
for stress dissipation (46). Abnormal tendon loading oc-
curs where the load is altered in terms of magnitude,
frequency, direction, or duration (47). In this cohort, the
greatest level of PDS was recorded in the region of the
navicular insertion; conceivably, this may be linked to
the increased TP activity in combination with the midfoot
collapse. The retromalleolar region of the TP tendon is a
known site for compressive stress, where the tendon
changes direction (48,49), and has a known component of
ﬁbrocartilage at the insertion and in the retromalleolar
region (50). There was evidence of abnormal thickening
and increased levels of ﬂuid in this region compared to
normal values, but the majority of subjects had either
absent or minor levels of PDS. However, the role of inﬂam-
matory factors cannot be underestimated due to the mod-
Table 4. Ultrasound features of the tibialis posterior (TP) tendon*
Variable
RA cohort (n  10) Published normal values
Mean  SD Range Mean  SD† Range
TP transverse, mm 9.4  0.9 7.4–10.9 8.4  4.2 3.1–14.1
TP longitudinal, mm 4.9  1.1 3.0–6.0 2.8  1.8 1.3–6.0
Ratio longitudinal:transverse 0.53  0.12 0.30–0.64 0.30  0.14 0.20–0.46
Fluid transverse, mm 2.3  1.6 0.7–4.9 1.2  1.6 0.2–3.8
Fluid longitudinal, mm 1.3  1.0 0.0–2.8
* Published values from 102 control subjects (33); normative ratio values from 15 control subjects (32).
RA  rheumatoid arthritis.
† 2 SDs.
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erate levels of disease activity present in the studied co-
hort. Synovial tissue is a primary target in RA, including
the synovial lining of tendons, and the effect of globally
active disease is a potentially confounding factor.
This study was subject to 4 main limitations. First, RA
is a systemic disease involving synovial tissue including
joints and tendons. Disease activity varied across the RA
patients, and TP involvement in those with moderate to
high levels of disease activity may be driven systemically
with little or no mechanical involvement. The global ef-
fects of the disease are likely to contaminate the ﬁndings
of detailed analysis of the foot and lower leg. Second, EMG
normalization techniques present limitations in groups
such as RA patients, where disease factors such as joint or
tendon pain inﬂuence capability to generate MVICs. While
the results are encouraging in terms of detecting a differ-
ence between the RA group and healthy controls, it is
impossible to separate the contribution of the normaliza-
tion method to the differences recorded. Despite the po-
tential inﬂuence of the normalization method, no differ-
ences were recorded for the other studied muscles. Third,
the small sample size does not provide adequate statistical
power for robust conclusions to be drawn. This must be
balanced against a complex protocol that has permitted
initial and important insights into mechanical and inﬂam-
matory factors in RA. Finally, the role of other factors,
particularly obesity, may confound the results and this
should be considered in future studies.
In summary, this study has demonstrated increased
magnitude of TP EMG in a cohort of patients with RA,
PPV, and US-conﬁrmed tenosynovitis. Both inﬂammatory
and mechanical factors are thought to be important drivers
of foot-related impairment and disability. However, previ-
ous studies have only considered one aspect, i.e., either
the mechanical deﬁcits or the frequency and distribution
of inﬂammatory lesions. Despite a small sample size, this
study shows for the ﬁrst time that inﬂammation and me-
chanical dysfunction coexist, exploiting capabilities with
3-D gait analysis and US imaging. It does not infer cause
and effect nor seek to make correlations between these
factors. It does, however, provide important insights as the
basis to encourage larger-scale studies that may inﬂuence
the future development of targeted intervention.
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